Vaccines

In case you missed them, we've compiled the top 5 articles from this past week.

The CDC’s ACIP recommends newly FDA-approved Shingrix as the preferred vaccine for the prevention of shingles in individuals 50 years of age or older.

As health officials continue to recommend the injectable influenza vaccine to prevent illness this season, a new study examines whether vaccination rates changed after the CDC stopped recommending the nasal spray vaccine

According to recent data from the Centers for Disease Control and Prevention, millions of Americans aged 13-17 are under-vaccinated against serious infectious diseases.

More information continues to be revealed about the Zika virus as research on a vaccine continues to advance as well.

A new CDC report finds that although vaccination coverage is high for kindergarteners in the United States, pockets of undervaccination are a cause for concern among health officials.

The FDA has approved Shingrix, GlaxoSmithKline’s recombinant zoster vaccine against shingles, for patients 50 and older.

Although there have been important improvements to existing vaccines, the list of vaccine-preventable diseases has barely changed at all in over two decades.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Both test vaccines produced immune responses by 1 month after vaccination and the immune response lasted for at least 1 year.

A new article details how researchers are working to develop a universal flu shot.

NIAID director Dr. Anthony S. Fauci stresses in a recent commentary that, from a practical standpoint, the development of a moderately effective HIV vaccine is “essential” to ending the pandemic.

The declaration was made to help direct funds towards controlling the outbreak and providing adult hepatitis A vaccines to those in need.

Dr. Daniel Lucey provided insight on past and current yellow fever outbreaks and vaccine shortages at ID Week 2017; he also cited the very real possibility of yellow fever hitting Asia.

Presenters combed through the barrage of clinical trials to share those that could be practice-changing for clinicians.

Thoughts leaders believe infectious disease treatment is in the middle of a sea change, moving from antibiotics to antibodies.

It is only a matter of time before the next infectious disease pandemic hits and healthcare officials need to be prepared.

Dr. Monique Foster, CDC, and Dr. Eric McDonald, San Diego County Health and Human Services Agency, discuss the surprising return of hepatitis A virus as part of the Late Breakers I symposium.

New data reveal that when pregnant women receive the Tdap vaccine during pregnancy, it can prevent whooping cough in about 78% of newborns; however, only about 50% of pregnant women receive the vaccine.

MNT occurs neonatally when a newborn’s unhealed umbilical stump is infected with Clostridium tetani, the bacterium that causes tetanus.

Officials from the Los Angeles County Department of Public Health declare a local hepatitis A outbreak, as HAV outbreaks continue in San Diego and Santa Cruz.

Hanneke Schuitemaker, PhD, explains the challenges faced when creating a vaccine for HIV.

As outbreaks of measles and mumps continue to spring up across the country, a third dose of the MMR vaccine may be necessary to cull their spread.

Researchers from the Moffitt Cancer Center find that the newest HPV vaccine protects against 9 cancer-causing strains of the virus.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jessica Justman, MD, reveals the latest results of the Population-based HIV Impact Assessment Project (2017).

Administration of the HPV vaccine continues to lag behind that of other recommended vaccines. How can providers increase the proportion of adolescents vaccinated against this sexually transmitted virus?

A FDA expert advisory panel voted unanimously to back a new shingles vaccine developed by GlaxoSmithKline: Shingrix.

After being hit with severe flooding and a devastating mudslide, thus increasing risk of cholera infection, half a million individuals in Sierra Leone will now have access to a life-saving vaccine.

Researchers have developed a map of the networks of B-cells in the human body, shedding light on the intricate workings of the immune system.